| Literature DB >> 31465501 |
Teppei Nakamura1,2, Osamu Ichii2, Yuji Sunden3, Yaser Hosny Ali Elewa2,4, Tomoji Yoshiyasu5, Hideki Hattori5, Osamu Tatsumi1, Yasuhiro Kon2, Ken-Ichi Nagasaki6.
Abstract
Developmental anomalies of the thyroid gland lead to congenital malformations such as thyroglossal duct cysts and thyroid dysgenesis. However, the pathogenesis of thyroid dysgenesis remains unclear due to the lack of suitable animal models. This study demonstrated that Slc:Wistar/ST rats frequently developed unilateral thyroid dysgenesis, including hemiagenesis, characterized by the absence of one lobe. In Wistar/ST rats, each thyroid lobe was frequently different in size, and approximately 27% and 20% of the rats presented with hemihypoplasia and hemiagenesis of the thyroid gland, respectively. Dysgenesis was predominant on the left side in both sexes, without sex differences. At a young age, thyroid hemiagenesis did not alter body weight. In rats of both sexes with thyroid hemiagenesis, plasma total triiodothyronine and total triiodothyronine levels remained unchanged while plasma thyroid-stimulating hormone levels were significantly elevated in young rats. The remaining thyroid lobes increased in weight, but the follicular epithelial cells appeared normal in terms of their height and proliferating activities. On the side of thyroid dysgenesis, the parathyroid glands were normally localized and were situated at the same location as the contralateral glands. The ultimobranchial body remnants were localized at the level of the thyroid gland along with the cranial thyroid artery and vein, forming cell clusters or cystic structures and containing calcitonin-positive C-cells. In conclusion, Wistar/ST rats developed unilateral thyroid dysgenesis and may be novel and useful animal models for thyroid hemiagenesis in humans and for morphogenesis of pharyngeal pouch-derived organs.Entities:
Year: 2019 PMID: 31465501 PMCID: PMC6715207 DOI: 10.1371/journal.pone.0221939
Source DB: PubMed Journal: PLoS One ISSN: 1932-6203 Impact factor: 3.240
Summary of ELISA performance.
| Hormone | Kit | Cross reactivity | Sensitivity | CV |
|---|---|---|---|---|
| Thyroid-stimulating hormone | Rat TSH ELISA Kit (cat. #: MBS726442, MyBioSource, CA, USA) | Specific for TSH | 0.1 ng/ml | <10% |
| Total triiodothyronine | Mouse/Rat T3, Total ELISA kit (cat. #: T3043T-100, Calbiotech, CA, USA) | Not reported | 0.25 ng/ml | <10% |
| Total thyroxin | Mouse/Rat T4, Total ELISA kit (cat. #: T4044T-100, Calbiotech) | Not reported | 1 μg/dl | <10% |
1) The value is calculated by the standard samples, since it is not reported by the manufacturer.
Summary of immunostaining conditions.
| Antigen | Blocking reagent | Primary antibody | Secondary antibody |
|---|---|---|---|
| Proliferating cell nuclear antigen (PCNA) | 10% normal rabbit serum (cat. #: 426052, Nichirei, Tokyo, Japan) | Goat polyclonal (cat. #: sc-9857, 1:2000, Santa Cruz, TX, USA) | Biotinylated rabbit anti-goat IgG (cat. #: 416022, prediluted, Nichirei) |
| Calcitonin | 10% normal goat serum (cat. #: 426042, Nichirei) | Rabbit polyclonal (cat. #: IS515, prediluted, DAKO, Glostrup, Denmark) | Biotinylated goat anti-rabbit IgG (cat. #: 426012, prediluted, Nichirei) |
| Pan-cytokeratin | 10% normal rabbit serum (cat. #: 426052, Nichirei) | Mouse monoclonal (clone AE1/AE3, 1:100, DAKO) | Biotinylated rabbit anti-mouse IgG+IgA+IgM (cat. #: 426032, prediluted, Nichirei) |
| p63 | 10% normal rabbit serum (cat. #: 426052, Nichirei) | Mouse monoclonal (clone 4A4, prediluted, Nichirei) | Biotinylated rabbit anti-mouse IgG+IgA+IgM (cat. #: 426032, prediluted, Nichirei) |
| Galectin-3 | 10% normal goat serum (cat. #: 426042, Nichirei) | Rabbit polyclonal (cat. #: bs-0721R, 1:300, Bioss, MA, USA) | Biotinylated goat anti-rabbit IgG (cat. #: 426012, prediluted, Nichirei) |
| Bcl-2 | 10% normal goat serum (cat. #: 426042, Nichirei) | Rabbit polyclonal (cat. #: sc-492, 1:200, Santa Cruz) | Biotinylated goat anti-rabbit IgG (cat. #: 426012, prediluted, Nichirei) |
| Nkx2-1 | 10% normal rabbit serum (cat. #: 426052, Nichirei) | Mouse monoclonal (clone SPT24, prediluted, Nichirei) | Biotinylated rabbit anti-mouse IgG+IgA+IgM (cat. #: 426032, prediluted, Nichirei) |
| Iba1 | 10% Normal goat serum (cat. #: 42604w2, Nichirei) | Rabbit polyclonal (cat. #: 019–19741, Fujifilm Wako, Osaka, Japan) | Biotinylated goat anti-rabbit IgG (cat. #: 426012, prediluted, Nichirei) |
| CD3 | 2.5% normal horse serum (cat. #: DK-8828, Vector, CA, USA) | Rabbit monoclonal (clone SP7, 1:100, Nichirei) | DyLight 594 conjugated horse anti-rabbit IgG (cat. #: DK-8828, Vector) |
| CD79a | 2.5% normal horse serum (cat. #: DK-8828, Vector) | Mouse monoclonal (clone HM57, 1:200, Novus, CO, USA) | DyLight 488 conjugated horse anti-mouse IgG (cat. #: DK-8828, Vector) |
Fig 1Unilateral thyroid dysgenesis in Wistar/ST rats.
(A) Gross features of the thyroid glands in Wistar/ST rats. In this case, the left lobe and isthmus of the thyroid gland is absent, and the parathyroid glands are localized alongside the trachea (arrowhead). TC: thyroid cartilage, TG: thyroid glands, Tr: trachea. (B and C) Ratio of small to large lobe weights of the thyroid glands compared among different rat strains (B) and between F0 and F1 litters from Wistar/ST rats with thyroid hemiagenesis (C). Mean values are expressed above the box plots. ST: Wistar/ST, Han: BrlHan:WIST@Jcl (GALAS). A significant difference from Wistar/ST rats of the same sex is indicated by ss P < 0.01 and sss P < 0.001, Mann-Whitney U test. (D) Prevalence of unilateral thyroid dysgenesis compared between F0 and F1 litters from Wistar/ST rats with thyroid hemiagenesis. (E and F) Relative weight of the large thyroid lobe (E) and that of the total thyroid glands (F) in Wistar/ST rats at 9 to 22 weeks of age. A significant difference from the control group at the same age is indicated by nn P < 0.01 and nnn P < 0.001, Kruskal-Wallis test followed by Scheffé’s method.
Prevalence of thyroid dysgenesis according to sex and laterality.
| Total | Female | Male | Female: male ratio | ||
|---|---|---|---|---|---|
| Sample size | 89 | 43 | 46 | ||
| Thyroid dysgenesis | 42 (47.2%) | 24 (55.8%) | 18 (39.1%) | 1.33 | |
| Hemihypoplasia | 24 (27.0%) | 13 (30.2%) | 11 (23.9%) | 1.18 | |
| Hemiagenesis | 18 (20.2%) | 11 (25.6%) | 7 (15.2%) | 1.57 | |
| Side of presentation | |||||
| Left | 35 (39.3%) | 18 (41.9%) | 17 (37.0%) | 1.06 | |
| Right | 7 (7.9%) | 6 (14.0%) | 1 (1.1%) | 6.00 |
Thyroid dysgenesis represents hemihypoplasia + hemiagenesis. The side of presentation is examined for the rats with thyroid dysgenesis.
Age-related changes of prevalence of thyroid dysgenesis.
| Total | 9–15 weeks | 16–22 weeks | P-value | |
|---|---|---|---|---|
| Sample size | 89 | 51 | 38 | |
| Thyroid dysgenesis | 42 (47.2%) | 25 (49.0%) | 17 (44.8%) | |
| Hemihypoplasia | 24 (27.0%) | 12 (23.5%) | 12 (31.6%) | |
| Hemiagenesis | 18 (20.2%) | 13 (25.5%) | 5 (13.2%) |
Fig 2Physiological and hormonal status in Wistar/ST rats.
(A) Body weight at 9 and 14 weeks of age. (B-D) Plasma levels of TSH (B), total T3 (C), and total T4 (D) at 7 to 14 weeks of age. (E) Plasma levels of TSH at 22 to 42 weeks of age. At panel E, the control group consists of 4 males and 12 females, and the hemiagenesis group consists of 2 males and 6 females. A significant difference from the control rats of the same sex is indicated as n P < 0.05 and nn P < 0.01, Mann-Whitney U test. A significant sex difference is indicated as m P < 0.05 and mm P < 0.01, Mann-Whitney U test.
Fig 3Histopathological features of thyroid glands in Wistar/ST rats.
(A) Transversal and frontal section of the thyroid glands. Es: esophagus, P: parathyroid gland, TG: thyroid gland, Tr: trachea. Asterisk and dagger indicate nodule and cystic structures, respectively. (B and C) HE section (B) and immunohistochemistry for PCNA (C) in the central region of the thyroid glands at 9 to 14 weeks of age.
Fig 4Histopathological features of the nodules and cystic structures in Wistar/ST rats.
(A and B) Localization of the blood vessels at the side of hemiagenesis (A) and hemihypoplasia (B). (C and D) Higher magnification of the nodules. HE sections (C) and PAS section (D). The nodules contain PAS-positive follicular structures and cell nests. (E-J) Immunohistochemistry of the nodules for calcitonin (E), pan-cytokeratin (F), p63 (G), galectin-3 (H), Bcl-2 (I), and Nkx2-1 (J). (K-M) Immune cell infiltration into the nodules. HE sections (K), immunohistochemistry for Iba1 (L), and immunofluorescence for CD3 and CD79a (M). CaA: caudal thyroid artery, CrA: cranial thyroid artery, CrV: cranial thyroid vein, TG: thyroid gland, Tr: trachea. Asterisks and daggers indicate nodules and cystic structures, respectively. Arrows and arrowheads indicate follicular structures and cell nests, respectively.
Fig 5Distribution of the laryngeal endocrine organs in Wistar/ST rats.
The right side represents normal development, and the left side shows thyroid hemiagenesis. Numbers I to IV indicate the number of pharyngeal pouches.